Carlos Turrado

Novel Epigallocatechin-3-Gallate (EGCG) Derivative as a New Therapeutic Strategy for Reducing Neuropathic Pain after Chronic Constriction Nerve Injury in Mice

J. Alberch, E. Verdú, T. Puig, 2015, PloS one.

Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity

H. Aguilar, A. Urruticoechea, D. Haro, 2009, Clinical Cancer Research.

Effective GTP-replacing FtsZ inhibitors and antibacterial mechanism of action.

P. Chacón, M. Artola, S. Sieber, 2015, ACS chemical biology.

New synthetic inhibitors of fatty acid synthase with anticancer activity.

M. Artola, D. Haro, M. López-Rodríguez, 2012, Journal of medicinal chemistry.

Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs

R. Brugada, M. Palafox, A. Massaguer, 2015, PloS one.

A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines

H. Aguilar, A. Urruticoechea, M. López-Rodríguez, 2011, Breast Cancer Research.